肝性脊髓病研究现状

Advances in research of hepatic myelopathy

肝性脊髓病(hepatic myelopathy,HM)是肝硬化晚期少见的神经系统并发症,大部分患者合并肝性脑病,常发生在门体分流术和(或)自体分流后,该病发病机制尚不明确,缺乏有效治疗方法,且预后不良。通过回顾相关文献,对发病机制、临床病理研究、临床特征、临床诊断标准、治疗和预后进行综述,以期提供借鉴。

Hepatic myelopathy （HM） is a rare complication at the last stage of chronic liver diseases, usually associated with hepatic eneephalopathy. The pathogenesis of the disease is unclear. It has a poor prognosis and has no effective treatment. Through review of relevant literature, the pathogenesis, pathological study, clinical features, and clinical diagnosis of the standard, treatment and prognosis were summarized to provide a reference.